Pfizer agrees to record $2.3-billion healthcare-fraud settlement
Pfizer Inc. and a subsidiary have agreed to a record healthcare fraud settlement and will pay $2.3 billion to resolve civil and criminal complaints in connection with the illegal promotion of some drugs, the Justice Department announced this morning.
Read article in the Los Angeles Times (USA)
Comment: The overall settlement is the largest ever paid by a drug company for alleged violations of federal drug rules. Drugs involved in the fraud included Bextra, an anti-inflammatory painkiller; Geodon, an anti-psychotic drug; Zyvox, an antibiotic; and Lyrica, an anti-epileptic drug.